At a time of unprecedented financial challenge within the NHS, the need to find solutions that can deliver efficiencies without compromising quality of care is common to all health systems.
At Arden & GEM, we are already supporting a range of organisations to meet ambitious financial targets, from analysing QIPP (Quality, Innovation, Productivity and Prevention) and CIP (Cost Improvement Programme) schemes and financial performance to developing new opportunities, in order to achieve large scale change.
By bringing together multidisciplinary expertise from functions including business intelligence, service transformation, finance and clinical support, we work collaboratively with you to ‘stress test’ current schemes, using analytics to unpick assumptions and delivery experience to test and develop plans. Working closely with clinical and operational leaders we can help produce a robust, evidence-based action plan that enables our clients to deliver the necessary improvements.
We continue to support the successful delivery of efficiencies by providing the ongoing analytics and insight required to ensure that delivery remains on track and that financial and clinical benefits are realised. We provide the dedicated resource, energy and determination required to strengthen efficiency delivery plans, reduce financial risk and enable quicker implementation.
Identifying relevant and realistic opportunities
Through our national work, research and analysis, we have built a wide library of successful change programmes informed by our knowledge team. We use this evidence base to support our customers to make improvements, at pace, building upon the learning of others. Our transformation specialists use this library, and their expertise, to source potential new project areas which our business intelligence experts then use to undertake comparative analysis to look for further opportunities and quantify the potential savings for identified areas.
Turning opportunities into improvements
By adopting an open, transparent and collaborative approach, the Arden & GEM team is able to support both commissioners and healthcare providers to manage change with all stakeholders across their health system. We build relationships and trust with our clients, using regular workshops and group sessions to maintain buy-in and test our approach for your environment
With a proven approach to change and programme management, our transformation service can implement efficiency plans with rigour and speed. From mapping the detailed activities required to deliver the programme, to setting up and managing governance processes, to monitoring benefits realisation, we can effectively deliver large-scale and complex programmes.
Our finance experts are also able to draw upon decision support tools, such as Best Possible Value (BPV) as well as our own best in class in-house solutions, to help review current and potential cost pressures and the financial impact of any improvements or interventions made.
With a range of in-house clinical expertise, we are also able to support improvements in the following areas:
Prescribing and medicines optimisation
Our team of experienced pharmacists and pharmacy technicians has worked with a number of CCGs to deliver prescribing and medicines optimisation QIPP schemes, including proposals for prescribing reviews and prescribing switches. With a thorough knowledge of ePACT2 data and NICE guidance, and a successful track record in engaging primary care, we can also implement any changes and recommendations at a practice or community level. To minimise the risk to CCGs and STPs we can deliver projects on an innovative gain share basis. Not only have our initiatives quickly delivered savings for the commissioner, they have also improved patient safety and reduced inappropriate use of medicines.
Clinical review and policy development
Ensuring the best clinical outcomes are achieved for patients, while local healthcare resources are utilised in the most efficient way, often requires a thorough review of treatment policies to ensure they are consistent and reflect the most up to date clinical evidence. We have worked with a number of local health systems to prepare evidence reviews and draft new policies, with a particular expertise in treatment policies for procedures with limited clinical effectiveness or restricted access. Our clinical support team is complemented by our engagement service, who have a range of experience in undertaking clinical and public engagement to ensure policy or service changes are informed by clinical opinion and patient experience.
One of the greatest opportunities to increase efficiency is reducing unwarranted variation in care. You can find out more about our specific Reducing clinical variation solution here.
We would welcome the opportunity to talk with you about working collaboratively to meet your efficiency challenges.
Arden & GEM is already helping healthcare systems to locate and deliver efficiency programmes. Find out more by accessing the resources below.
Following a year of unprecedented challenges for the healthcare system, NHS Arden & GEM CSU is pleased to share its annual review for 2020/21.
For the financial year April 2020 to March 2021, Arden & GEM’s finance and payroll teams were given full assurance by the auditors and issued a clean audit opinion.
NHS Arden & GEM CSU’s procurement team has been successful in the ‘Team of the Year’ category at the Healthcare Financial Management Association (HFMA) East Midlands Brand Annual Awards 2021/21.
On behalf of the MK:5G Connected Communities Project, our Head of Digital Transformation, Adrian Smith has been invited to speak at two virtual events aimed at showcasing and exploring opportunities for enhanced healthcare with the provision of a city-wide 5G network.
Mark Smith has been appointed as NHS Arden & GEM Commissioning Support Unit’s new Director of Finance, bringing 20 years of senior financial leadership experience within the healthcare sector.
Arden & GEM’s medicines optimisation team has had an article published in the latest issue of the Journal of Pharmacy Management, covering an innovative project to accelerate the uptake of biosimilars with a high cost drugs in-reach pharmacist.
Arden & GEM’s medicines optimisation team identified an opportunity for South Warwickshire Clinical Commissioning Group (CCG) to boost its QIPP savings plan by accelerating the uptake of biosimilars to treat rheumatological conditions
To support South Warwickshire Clinical Commissioning Group (CCG) in the delivery of its prescribing and medicines optimisation QIPP scheme savings, Arden & GEM proposed a plan to review potential areas for prescribing switches, identify patients and implement the change.
Arden & GEM managed and delivered an 18 month project, on behalf of NHS Birmingham and Solihull CCG and NHS Sandwell and West Birmingham CCG, to develop 22 harmonised policies, ready for implementation in January 2019. The new policies will ensure the best clinical outcomes are achieved for patients and local healthcare resources are utilised in the most efficient way.
Faced with ambitious financial targets, Solihull Clinical Commissioning Group (CCG) needed to develop their current Quality, Innovation, Productivity and Prevention (QIPP) schemes to achieve the scale of change required. The CCG commissioned our service transformation and business intelligence experts to help them find greater, and faster, savings.
If you’d like to find out more about delivering efficiency through QIPP, please contact us here: